Evidence map›Paper›PMID 10557104›Full record

ReviewOncogene1999

Regulated nuclear localization of stress-responsive factors: how the nuclear trafficking of protein kinases and transcription factors contributes to cell survival.

P Ferrigno, P A Silver

Abstract readReview
PubMed Publisher
In one paragraph

Review in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The p38 Pathway: From Biology to Cancer Therapy.International journal of molecular sciences · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Potential effects of CRM1 inhibition in mantle cell lymphoma.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2012
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Sequence conserved for subcellular localization.Protein science : a publication of the Protein Society · 2002
    Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

P FerrignoDepartment of Cancer Biology, The Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts, MA 02115, USA.
P A Silver
Dana-Farber Cancer Institute · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The details of nuclear transport mechanisms are emerging rapidly, largely through work with model organisms. Here, we briefly describe these advances, with an emphasis on the remaining challenges. We then address the nuclear transport of some high profile cellular regulators, including p53 and the proto-oncogene PKB/Akt. We discuss the mechanisms that contribute to the differential subcellular localization of these proteins. Finally, we analyse the provocative patterns that emerge from our overview.

Indexed as

Protein Serine-Threonine KinasesAnimalsApoptosisBiological TransportCell NucleusCell SurvivalMAP Kinase Signaling SystemProtein KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTranscription FactorsTumor Suppressor Protein p53Protein KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID10557104
OpenAlexW2069976309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.